| Product NDC: | 57451-5066 |
| Proprietary Name: | Famotidine |
| Non Proprietary Name: | Famotidine |
| Active Ingredient(s): | 20 mg/1 & nbsp; Famotidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 57451-5066 |
| Labeler Name: | Ipca Laboratories Limited |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA090283 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100723 |
| Package NDC: | 57451-5066-1 |
| Package Description: | 10000 TABLET in 1 POUCH (57451-5066-1) |
| NDC Code | 57451-5066-1 |
| Proprietary Name | Famotidine |
| Package Description | 10000 TABLET in 1 POUCH (57451-5066-1) |
| Product NDC | 57451-5066 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Famotidine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100723 |
| Marketing Category Name | ANDA |
| Labeler Name | Ipca Laboratories Limited |
| Substance Name | FAMOTIDINE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |